Global Antiviral Peptide Research: A Bibliometric Analysis from 1951 to 2022
Authors:
- Wahyu Aristyaning PutriWPWahyu Aristyaning Putri
- Jajar SetiawanJSJajar Setiawan
- Fajar SofyantoroFSFajar Sofyantoro
- Wulan Usfi MafirohWMWulan Usfi Mafiroh
- Dwi Sendi PriyonoDPDwi Sendi Priyono
- Nur Indah SeptrianiNSNur Indah Septriani
- Abdul Rahman SiregarASAbdul Rahman Siregar
- Yekti Asih PurwestriYPYekti Asih Purwestri
- Anjar Tri WibowoAWAnjar Tri Wibowo
- Tri Rini NuringtyasTNTri Rini Nuringtyas
Open Access
- 16 September 2024
- journal article
- Published by Editorial Pontificia Universidad Javeriana in Universitas Scientiarum
- Vol. 29 (3) , 229-251
Abstract
Antiviral peptides (AVPs) are small molecules that inhibit the replication of viruses in living cells. AVPs are being investigated as potential alternatives to traditional antiviral drugs. The development of novel antiviral agents is of the highest concern because some traditional antiviral medications can be ineffective and lead to resistant viruses emergence. We conducted a bibliometric study on the global distribution of AVP research to comprehend the trends and patterns in the field. For this analysis, we retrieved data from the Scopus database on AVP-related publications from 1951 to 2022, including the number of publications, citations, and authors. Overall, 10,279 papers were published, with an annual average of 146 publications. The United States released the most documents, followed by China, Germany, and the United Kingdom. Since 2001, there has been a substantial increase in global publications on AVPs, with prominent themes including virology, genetics, protease inhibitors, polypeptide antimicrobial agents, and viral entry. This bibliometric analysis can be used to guide future research in this field.Keywords
This publication has 55 references indexed in Scilit:
- Identification of multi-targeting natural antiviral peptides to impede SARS-CoV-2 infectionStructural Chemistry, 2022
- Peptide-Based Vaccines and Therapeutics for COVID-19International Journal of Peptide Research and Therapeutics, 2022
- Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)JAMA Cardiology, 2020
- Antiviral Peptides: Identification and ValidationInternational Journal of Peptide Research and Therapeutics, 2020
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challengesInternational Journal of Antimicrobial Agents, 2020
- Antiviral peptides as promising therapeutic drugsCellular and Molecular Life Sciences, 2019
- An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza VirusesImmunity, 2017
- Software survey: VOSviewer, a computer program for bibliometric mappingScientometrics, 2009
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticlesJournal of Controlled Release, 2008
- Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virusInternational Journal of Antimicrobial Agents, 2004